Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage:
PZRX 143.37% – News: PRX-OTC receives Orphan Drug Designation
EMGL 47.06% – News: Posts Q3 financial results, GAAP revenues increase 133%
EPIX 31.93% – News: Secures $10 million term loan
REPH 23.58%– News: Positive results from second phase III clinical trial for Meloxicam
MRIC 17.92% – News: ClearPoint® will be exhibited at AES Annual Meeting December 2 – 6, 2016, in Houston
STEM 11.79% – News: Merges with Microbot Medical; will begin trading on NASDAQ as ‘MBOT’
IEGH 11.11% – News: Announces private offering of $10M of 12% unsecured notes
CDEV 9.21% – News: Will acquire 100% of Silverback Exploration upstream assets for $855M
ACST 8.87% – News: Names Linda O’Keefe as CFO
MKTY 5.52% – News: Details acquisition-based growth strategy
About NetworkNewsBreaks
NetworkNewsBreaks (NNB) provide a rapid summary of corporate news that caught the attention of NetworkNewsWire (NNW). NNB keeps you up-to-date on active US Public Companies complementary to NNW’s broader scope as a provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.networknewswire.com.
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
